Newsletters
Nautilus Navigator
Eagle Edge
NYL Investments
Press & Announcements
Carrie Hall honored with Founders’ Award from Fresh Start
Carrie Hall, a financial advisor and founder of a Scottsdale-based wealth management practice, has been honored with the Founders' Award from Fresh Start. Fresh Start is a nonprofit organization in Phoenix, Arizona, dedicated to empowering women and helping them achieve financial stability and fulfillment. The award recognizes Hall's significant contributions to the community through her volunteer work and philanthropic initiatives.
I am so proud to have partnered with New York for the last 35 years to provide excellent insurance, annuity, and long-term care solutions to our clients. Please click the link above to review the 2022 investment results for New York Life which continues to be in the Fortune 100 companies as a company owned by policyholders and the largest mutual insurance company in the US. With integrity, financial strength, and humanity as their core values, they perfectly align with the values Of the families and businesses we represent.
NYL announces strong 2022 financial results underscoring company’s robust strength and stability.
New York Life, America’s largest mutual life insurer, today announced strong financial results for 2022 that underscore the power of the company’s differentiated business model and its significant contributions to New York Life’s enduring financial strength.
Carrie Hall Named New York Life's 2022 Council President
New York Life today announced the appointment of Carrie Hall as its 2022 Council President, an honor afforded to the top-ranking agent among New York Life’s more than 12,000 financial professionals.
2022 Barrow Grand Ball Raises Record-Breaking $10.4M, Supports Diabetes Research
For 2022, the Grand Ball committee selected the innovative research of Zaman Mirzadeh, MD, PhD, a researcher and neurosurgeon at Barrow, as its project. Dr. Mirzadeh is investigating brain-based approaches to controlling blood sugar that have the potential to pave the way for new, groundbreaking therapies for those battling type 1 and type 2 diabetes.
